Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1560.37%
operating margin TTM
-1706.75%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.75 |
| peg ratio | -0.01 |
| price to book ratio | 1.06 |
| price to sales ratio | 11.61 |
| enterprise value multiple | -0.74 |
| price fair value | 1.06 |
profitability ratios | |
|---|---|
| gross profit margin | 63.79% |
| operating profit margin | -1706.75% |
| pretax profit margin | -1590.6% |
| net profit margin | -1560.37% |
| return on assets | -91.93% |
| return on equity | -102.12% |
| return on capital employed | -123.16% |
liquidity ratios | |
|---|---|
| current ratio | 4.29 |
| quick ratio | 4.29 |
| cash ratio | 0.46 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 1,277.24 |
| cash conversion cycle | -1,277.24 |
| receivables turnover | 0.00 |
| payables turnover | 0.29 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.18 |
| debt equity ratio | 0.28 |
| long term debt to capitalization | 0.20 |
| total debt to capitalization | 0.22 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -3.79 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.16 |
| cash per share | 1.22 |
| operating cash flow per share | -1.16 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.79 |
| short term coverage ratios | -44.40 |
| capital expenditure coverage ratio | -8,040.56 |
Frequently Asked Questions
When was the last time Pyxis Oncology, Inc. (NASDAQ:PYXS) reported earnings?
Pyxis Oncology, Inc. (PYXS) published its most recent earnings results on 03-11-2025.
What is Pyxis Oncology, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Pyxis Oncology, Inc. (NASDAQ:PYXS)'s trailing twelve months ROE is -102.12%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Pyxis Oncology, Inc. (PYXS) currently has a ROA of -91.93%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PYXS's net profit margin stand at?
PYXS reported a profit margin of -1560.37% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PYXS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.29 in the most recent quarter. The quick ratio stood at 4.29, with a Debt/Eq ratio of 0.28.